BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

150 related articles for article (PubMed ID: 37753954)

  • 21. Major basic protein is a useful marker to distinguish eosinophilic esophagitis from IBD-associated eosinophilia in children.
    Butzke S; Nasiri-Blomgren S; Corao-Uribe D; He Z; Molle-Rios Z
    J Pediatr Gastroenterol Nutr; 2024 Mar; 78(3):555-564. PubMed ID: 38314865
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Eosinophilic Gastritis/Gastroenteritis.
    Chen PH; Anderson L; Zhang K; Weiss GA
    Curr Gastroenterol Rep; 2021 Jul; 23(8):13. PubMed ID: 34331146
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Joint ESPGHAN/NASPGHAN Guidelines on Childhood Eosinophilic Gastrointestinal Disorders Beyond Eosinophilic Esophagitis.
    Papadopoulou A; Amil-Dias J; Auth MK; Chehade M; Collins MH; Gupta SK; Gutiérrez-Junquera C; Orel R; Vieira MC; Zevit N; Atkins D; Bredenoord AJ; Carneiro F; Dellon ES; Gonsalves N; Menard-Katcher C; Koletzko S; Liacouras C; Marderfeld L; Oliva S; Ohtsuka Y; Rothenberg ME; Strauman A; Thapar N; Yang GY; Furuta GT
    J Pediatr Gastroenterol Nutr; 2024 Jan; 78(1):122-152. PubMed ID: 38291684
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Biologics in eosinophilic gastrointestinal diseases.
    Dellon ES; Spergel JM
    Ann Allergy Asthma Immunol; 2023 Jan; 130(1):21-27. PubMed ID: 35738437
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Benralizumab for eosinophilic gastritis: a single-site, randomised, double-blind, placebo-controlled, phase 2 trial.
    Kliewer KL; Murray-Petzold C; Collins MH; Abonia JP; Bolton SM; DiTommaso LA; Martin LJ; Zhang X; Mukkada VA; Putnam PE; Kellner ES; Devonshire AL; Schwartz JT; Kunnathur VA; Rosenberg CE; Lyles JL; Shoda T; Klion AD; Rothenberg ME
    Lancet Gastroenterol Hepatol; 2023 Sep; 8(9):803-815. PubMed ID: 37336228
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Diagnostic Delay in Patients with Eosinophilic Gastritis and/or Duodenitis: A Population-Based Study.
    Chehade M; Kamboj AP; Atkins D; Gehman LT
    J Allergy Clin Immunol Pract; 2021 May; 9(5):2050-2059.e20. PubMed ID: 33440255
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Primary Eosinophilic Gastrointestinal Diseases Beyond Eosinophilic Esophagitis in Children.
    Egritas Gurkan O; Ozturk H; Karagol HIE; Ceylan K; Duztas DT; Ekinci O; Sari S; Dalgic B; Bakirtas A
    J Pediatr Gastroenterol Nutr; 2021 Feb; 72(2):294-299. PubMed ID: 32868666
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Natural Histories and Disease Complications in a Cohort of 151 Children With Gastric or Duodenal Eosinophilia.
    Quinn LA; Burger C; Nguyen B; Arnold MA; Pan Z; Furuta GT; Bauer ME; Menard-Katcher C
    Am J Gastroenterol; 2024 Feb; ():. PubMed ID: 38174865
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Dupilumab in adolescent eosinophilic esophagitis: Experience with fibrostenosis and eosinophilic gastrointestinal disease with esophageal involvement.
    Becker R; Rigsby M; Suchi M; Lerner DG; Chugh A
    J Pediatr Gastroenterol Nutr; 2024 Jun; 78(6):1337-1341. PubMed ID: 38587127
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Anti-Siglec-8 Antibody for Eosinophilic Gastritis and Duodenitis.
    Dellon ES; Peterson KA; Murray JA; Falk GW; Gonsalves N; Chehade M; Genta RM; Leung J; Khoury P; Klion AD; Hazan S; Vaezi M; Bledsoe AC; Durrani SR; Wang C; Shaw C; Chang AT; Singh B; Kamboj AP; Rasmussen HS; Rothenberg ME; Hirano I
    N Engl J Med; 2020 Oct; 383(17):1624-1634. PubMed ID: 33085861
    [TBL] [Abstract][Full Text] [Related]  

  • 31. The Severity of Reduced Esophageal Distensibility Parallels Eosinophilic Esophagitis Disease Duration.
    Araujo IK; Shehata C; Hirano I; Gonsalves N; Kahrilas PJ; Tetreault MP; Schauer JM; Farina D; Peterson S; Kou W; Pandolfino JE; Carlson DA
    Clin Gastroenterol Hepatol; 2024 Mar; 22(3):513-522.e1. PubMed ID: 37164112
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Esophageal Fibrosis in Eosinophilic Gastrointestinal Diseases.
    Thaker AI; Melo DM; Samandi LZ; Huang R; Park JY; Cheng E
    J Pediatr Gastroenterol Nutr; 2021 Mar; 72(3):392-397. PubMed ID: 33230074
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Efficacy of Dupilumab in a Phase 2 Randomized Trial of Adults With Active Eosinophilic Esophagitis.
    Hirano I; Dellon ES; Hamilton JD; Collins MH; Peterson K; Chehade M; Schoepfer AM; Safroneeva E; Rothenberg ME; Falk GW; Assouline-Dayan Y; Zhao Q; Chen Z; Swanson BN; Pirozzi G; Mannent L; Graham NMH; Akinlade B; Stahl N; Yancopoulos GD; Radin A
    Gastroenterology; 2020 Jan; 158(1):111-122.e10. PubMed ID: 31593702
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Clinical, histopathological features and efficacy of elimination diet and proton-pump inhibitor therapy in achieving histological remission in Asian children with eosinophilic gastritis.
    Ng LQ; Loh W; Ong JX; Merchant K; Chiou FK
    J Paediatr Child Health; 2022 Jul; 58(7):1244-1250. PubMed ID: 35388934
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Comparison of 2 delivery vehicles for viscous budesonide to treat eosinophilic esophagitis in children.
    Rubinstein E; Lee JJ; Fried A; Logvinenko T; Ngo P; McDonald D; Hait EJ
    J Pediatr Gastroenterol Nutr; 2014 Sep; 59(3):317-20. PubMed ID: 24821535
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Benralizumab Completely Depletes Gastrointestinal Tissue Eosinophils and Improves Symptoms in Eosinophilic Gastrointestinal Disease.
    Kuang FL; De Melo MS; Makiya M; Kumar S; Brown T; Wetzler L; Ware JM; Khoury P; Collins MH; Quezado M; Pittaluga S; Klion AD
    J Allergy Clin Immunol Pract; 2022 Jun; 10(6):1598-1605.e2. PubMed ID: 35283330
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Clinical Evaluation of the Child with Eosinophilic Esophagitis.
    Bauer M; Nguyen N; Liacouras CA
    Immunol Allergy Clin North Am; 2024 May; 44(2):157-171. PubMed ID: 38575215
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Impressions and aspirations from the FDA GREAT VI Workshop on Eosinophilic Gastrointestinal Disorders Beyond Eosinophilic Esophagitis and Perspectives for Progress in the Field.
    Rothenberg ME; Hottinger SKB; Gonsalves N; Furuta GT; Collins MH; Talley NJ; Peterson K; Menard-Katcher C; Smith M; Hirano I; Genta RM; Chehade M; Gupta SK; Spergel JM; Aceves SS; Dellon ES
    J Allergy Clin Immunol; 2022 Mar; 149(3):844-853. PubMed ID: 34953790
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Comparison of Nonesophageal Eosinophilic Gastrointestinal Disorders with Eosinophilic Esophagitis: A Nationwide Survey.
    Yamamoto M; Nagashima S; Yamada Y; Murakoshi T; Shimoyama Y; Takahashi S; Seki H; Kobayashi T; Hara Y; Tadaki H; Ishimura N; Ishihara S; Kinoshita Y; Morita H; Ohya Y; Saito H; Matsumoto K; Nomura I
    J Allergy Clin Immunol Pract; 2021 Sep; 9(9):3339-3349.e8. PubMed ID: 34214704
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Eosinophilic gastrointestinal disorders in children and adolescents: A single-center experience.
    Votto M; Raffaele A; De Filippo M; Caimmi S; Brunero M; Riccipetitoni G; Marseglia GL; Licari A
    Dig Liver Dis; 2022 Feb; 54(2):214-220. PubMed ID: 34274254
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 8.